您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8420 处方药 8047 非处方药 267 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 妇科药物->更年期综合症
处方药:处方药
包装规格: 0.05毫克/贴剂 8贴剂/盒
计价单位:
  点击放大  
生产厂家中文参考译名:
华生实验室
生产厂家英文名:
WATSON LABS
该药品相关信息网址1:
www.alora.com/
该药品相关信息网址2:
www.drugs.com/mtm/alora.html
该药品相关信息网址3:
www.rxlist.com/alora-drug.htm
原产地英文商品名:
ALORA 0.05MG/PATCH 8PATCHES/BOX
原产地英文药品名:
ESTRADIOL
中文参考商品译名:
ALORA 0.05毫克/贴剂 8贴剂/盒
中文参考药品译名:
雌二醇
原产地国家批准上市年份:
1996/12/20
英文适应病症1:
Moderate to severe symptoms of vasoconstriction
英文适应病症2:
Vulvovaginal atrophy symptoms
临床试验期:
完成
中文适应病症参考翻译1:
中重度血管收缩症状
中文适应病症参考翻译2:
外阴阴道萎缩症状
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20127601213633.PDF)的“原文Priscribing Information”为准
---------------------------------------------------------------
 部分中文Alora处方资料(仅供参考)

英文药名: Alora (Estradiol Transdermal Patch)

中文药名: 雌二醇贴剂

FDA批准雌二醇缓释经皮给药系统安全标示的修改
    2005年5月19日,FDA批准修改雌二醇缓释经皮给药系统(estradiol,Alora)标签中的禁忌证和警告事项内容,以警示:本品可能增加痴呆、脑卒中、肺栓塞和深度静脉栓塞的风险。
  本品禁用于肝功能不全、患有肝病或对本品所含成分过敏的患者。尽管早期妊娠女性意外地使用了雌激素或孕激素后,几乎没有增加出生缺陷的风险,但妊娠女性或疑似妊娠的女性仍应避免服用本品。
  雌激素和(或)孕激素不应用于预防痴呆或心血管疾病。此项警告基于女性健康倡导行动(WHI)的一项研究的结果得出。此项安慰剂对照临床研究显示,结合雌激素+醋酸甲羟孕酮(medroxyprogesterone acetate)疗法使65岁及以上女性在4年中诊断为可能痴呆的比率显著增高。WHI研究的5年结果显示,与安慰剂组相比,结合雌激素+醋酸甲羟孕酮疗法用于50~79岁绝经后女性,导致脑卒中、肺栓塞和深度静脉栓塞的比例显著增加。
  本品由Watson Laboratories公司生产,适用于治疗绝经相关的中重度血管收缩症状和外阴阴道萎缩症状。

Generic Name for ALORA
Estradiol 0.025mg/day, 0.05 mg/day, 0.075 mg/day, 0.1 mg/day; transdermal patch.

Legal Classification:
Rx

Pharmacological Class for ALORA
Estrogen.

Manufacturer of ALORA
Watson Pharmaceuticals, Inc.
 
Indications for ALORA
Moderate to severe vasomotor symptoms of menopause. Vulval and vaginal atrophy. Postmenopausal osteoporosis prevention. Hypoestrogenism.

Adult dose for ALORA
Apply to clean, dry area on lower abdomen, hips, or buttocks (avoid breasts, waistline). Osteoporosis: initially one 0.025mg/day patch twice weekly. Others: initially one 0.05 mg/day patch twice weekly. Maintenance: use lowest effective dose. Patients without intact uterus may use continuous schedule; otherwise use cyclically (3 weeks on, 1 week off). Transferring from other topical therapy: may start immediately or if from oral estrogens: apply 1st patch up to 1 week after last oral dose. Rotate application sites. Reevaluate periodically.

Children's dosing for ALORA
Not applicable.

Contraindications for ALORA
Undiagnosed abnormal genital bleeding. Thromboembolic disorders. Thrombophlebitis. Breast or estrogen-dependent carcinoma. Pregnancy (Cat.X).

Warnings/Precautions for ALORA
Patients with intact uterus should receive a progestin to avoid endometrial hyperplasia. Familial hyperlipoproteinemia or history of breast cancer. Hypercoagulability. Hepatic insufficiency. Conditions aggravated by fluid retention. Endometriosis. Gallbladder disease. Bone disease associated with hypercalcemia. Do initial complete physical and repeat annually (include Pap smear, mammogram, and BP). Discontinue if hypertension or jaundice occurs and during immobilization, or at least 2 weeks before surgery associated with increased risk of thromboembolism. Nursing mothers.

Adverse Reactions for ALORA
See literature. Increased risk of endometrial cancer or hyperplasia, thromboembolic disorders. Headache, local irritation, fluid retention, breakthrough bleeding, mastodynia, nausea, abdominal cramps, migraine, dizziness; vaginal bleeding (at 0.1mg/day dose).

How is ALORA supplied?
Patch 0.05 mg/day—8, 24
0.025mg/day, 0.075 mg/day, 0.1 mg/day—8

Related Disease:
Menopausal disorders
Osteoporosis~estrogens

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20127601213633.PDF)的“原文Priscribing Information”为
---------------------------------------------------------------

更新日期: 2012-9-12
附件:




20127601213633.PDF    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com